We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Wpp Plc | LSE:WPP | London | Ordinary Share | JE00B8KF9B49 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-7.40 | -0.92% | 796.40 | 795.40 | 796.00 | 797.00 | 774.60 | 782.00 | 4,602,130 | 16:35:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Advertising Agencies | 14.84B | 110.4M | 0.1027 | 77.51 | 8.56B |
Date | Subject | Author | Discuss |
---|---|---|---|
05/12/2016 16:12 | Of course, DOW could end up putting on say c12.00% for this fourth Segment...that would lead to c20030. However, surely this would not be a single wave advance or would it! | nasdaqpat | |
05/12/2016 16:02 | A less manipulated and, arguably, more astutely managed FTSE100 cannot hope to properly rally when America is due a decent size Down wave...albeit c(03.00%) might be enough if the current Segment (S4) is to be stronger than a mere bolt-on. | nasdaqpat | |
05/12/2016 15:46 | DOW @ the earlier 19275 has put on 07.78% in 20 days. A quick scan of my records reveals that the last 20+ day Up wave for DOW started on 22 Apr 2013 when it Added 07.60% (14444:15542) in 23 days...that was followed by a 22 day, (06.38%) mini-correction. | nasdaqpat | |
05/12/2016 15:09 | Crazy markets...earlier reduced ever so slightly on FTSE Trackers and re-bought initial tranche of the dog SKY (WPP still too expensive). Up to 41 companies but stock level still @ 68.1%. Shorted DOW @ 19230.1 & 19260.1. Closed first short for (25) points. Order @ *19290...may change that to 19310 as my original target was for DOW to put on c08.00% in Bolt-On and reach c19315. *Edit changed order to 19310. | nasdaqpat | |
02/12/2016 16:51 | Market performed against the FTSE100 today with 15 Shares Up, 22 Down and 3 Unchanged. The week as a whole was goodish as our portfolio was moderately better than the FTSE100 with investments Down (01.21%) as opposed to FTSE100 which was Down (01.61%) (6841:6731). Overall, our assets were Down (00.76%) on the week. The calendar year performance table now stands at :- Gateside~~~+15.80%~~ FTSE100~~~~+11.47%~~ FTSE AS~~~~+09.88%~~(3444 Videans~~~~+05.21%~~ FTSE250~~~~+04.06%~~ Took advantage of some market weakness to increase our overall stock level to 68.2% from 62.6% at the end of last week. Hoping for more definitive interim lows early next week. | nasdaqpat | |
02/12/2016 10:36 | Re-bought initial tranche of JMAT @ 3058p so now 40 companies and stock level increased to 68.1%. | nasdaqpat | |
02/12/2016 09:21 | Yea I did well from CRST and BKG Not too happy about share buybacks at bkg. I prefer dividends as it allows me to add or buy stocks without selling existing holdings. I have a bit more to top up on GSK and AZN to get same holding size as IMB and BATS. Don't know why these dollar earners dropped so much when pound still weak. These so called bond proxies ppl are selling off I'm buying as I expect interest rates to stay low for longerI've also been considering buying ULVR and SGE both very sound businesses albeit with much less dividends. | invisage | |
02/12/2016 08:51 | Assuming 6677 is lowered today, then FTSE has now declined for 38 days following the intraday ath of 7130 on 11 Oct. Still not sure whether there will be further weakness on Monday following an Italian Referendum 'No' vote on Sunday. Also not sure about Adding further to FTSE100 Trackers whilst DOW has yet to come off its pedestal even one iota. | nasdaqpat | |
02/12/2016 08:19 | Credit where credit...you've done well with those house builder sallies! | nasdaqpat | |
02/12/2016 08:13 | Swapped my BKG for GSK | invisage | |
01/12/2016 18:34 | 9 up, 1 level, too many downOil saves the day again. Very mixed fortunes of shares in portfolio over recent weeks. VOD on a serious downward slide! | gateside | |
01/12/2016 16:37 | Modestly outperformed FTSE100 today with 18 Shares Up, 19 Down and 2 Unchanged. Stock level Up to 67.3%. WPP weak today but still hasn't lowered the 11 Nov interim low of 1634p so not interested in re-buying just yet awhile. DOW got to 19214 earlier...need some protection so put in an order @ 19220 (below current high of 19225) so not fired...win some, lose some! | nasdaqpat | |
01/12/2016 11:42 | Technically, today is Day 15 of the prospective third principal wave Down but, @ the earlier 6703, still only (04.20%) off 6997. However, the current corrective low of 6677 has now come well into view and it should be just a question of how much lower than that level FTSE goes before an interim low is established. | nasdaqpat | |
01/12/2016 11:13 | As intended, more tracker shares Added @ c6705...overall stock level now Up to 67.0%. | nasdaqpat | |
01/12/2016 08:05 | Consequently, cashed DOW short for 68 points profit! | nasdaqpat | |
01/12/2016 07:31 | The 'No' vote for Sunday is actually 4/1 On so maybe there won't be that much downward movement in the markets as the negative surprise factor doesn't really exist. The FED meet on 13-14 Dec so maybe that will generate some weakness if they raise interest rates. Who knows but I can't see FTSE rallying properly until a more plausible base has been registered. | nasdaqpat | |
30/11/2016 23:54 | I also fancy BATS below 4000p but am more focused on the Italian referendum now and am expecting weakness thru to next Monday. DOW short taken @ 19203.7 will need to be held until at least Sunday night to offer some semblance of a hedge against substantial FTSE tracker holdings. Nevertheless, I intend to Add further tracker shares in 3 tranches @ c6705, c6650 & c6590. My short-term target for FTSE remains c6589 which represents a c(04.25%) decline from last Wednesday's sub-wave top of 6881 and would possibly complete FTSE's third principal wave Down from 6997 on 10 Nov giving a decline of c(05.83%). The total decline for the 3 principal waves Down (7130:6930:7067:6677 | nasdaqpat | |
30/11/2016 23:39 | Indeed - That is my purpose for buying them....they have not only paid dividends but have increased them over many many years. 1) Evidenced based investing suggests tracker funds tend to do well over the long term. 2) Barclays study suggests most returns from stocks come from Dividends in the long term. 3)Companies with high ROCE tend to generate decent returns over the long term. In a nutshell those 3 points cover my investment strategy. | invisage | |
30/11/2016 23:33 | I did say that. But after today's news I'm less convinced about their prospects. I bought them at £18 and sold at £40 and collected many dividends on the way.Even though prospects might not be as good, the dividend should be safe. | gateside | |
30/11/2016 23:31 | IMB yields 5% that is attractive | invisage | |
30/11/2016 23:30 | yes but that impacts the UK - IMB only makes 18% of revenue from the UK I recall you saying you would buy back BATS at £40 Anyway I bought for the dividends and the growth of the dividends. I hope I can hold these for many many years | invisage | |
30/11/2016 22:55 | The news today about the Tobacco companies loosing their plain packaging appeal, is why I sold BATS earlier in the year. The sector has had a fantastic run, but there are better opportunities elsewhere, in my opinion now. | gateside | |
30/11/2016 18:30 | 19 up, 1 flat, 14 down Bought some AZN as a core holding, will add if it keeps dropping. I have decent holdings in IMB, BATS, AZN and GSK. They form part of my core portfolio alongside my trackers. I will use dividends from these stocks and trackers to add to new and existing positions. Unless something drastic happens to fundamentals I don't plan to trade my core holdings. I am fully invested now and will look to deploy dividend cash when possible. Apart from shifting a few holdings here and there I am with my portfolio going into 2017. | invisage |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions